Skip to main content
Erschienen in: Annals of Surgical Oncology 6/2013

01.06.2013 | Healthcare Policy and Outcomes

Readmission After Pancreatic Resection is not an Appropriate Measure of Quality

verfasst von: Irmina Gawlas, BA, Monica Sethi, MD, Megan Winner, MD, MS, Irene Epelboym, MD, James L. Lee, MD, Beth A. Schrope, MD, PhD, John A. Chabot, MD, John D. Allendorf, MD

Erschienen in: Annals of Surgical Oncology | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Hospital readmission has been proposed as a metric for quality of medical and surgical care. We examined our institutional experience with readmission after pancreatic resection, and assessed factors predictive of readmission.

Methods

We reviewed 787 pancreatic resections performed at a single institution between 2006 and 2010. Univariate and multivariate logistic regression models were used to assess the relationships between preoperative and postoperative characteristics and readmission. Reasons for hospital readmission were examined in detail.

Results

We found the 30-day readmission rate after pancreatic resection to be 11.6 %. In univariate analysis, young age, pancreaticoduodenectomy versus other operations, open versus laparoscopic technique, fistula formation, the need for reoperation, and any complication during the index hospitalization were predictive of readmission. In multivariate analysis, only young age and postoperative complication were predictive of readmission. Vascular resection, postoperative ICU care, length of stay, and discharge disposition were not associated with readmission. The most common reasons for readmission were leaks, fistulas, abscesses, and wound infections (45.1 %), delayed gastric emptying (12.1 %), venous thrombosis (7.7 %), and GI bleeding (7.7 %).

Conclusions

We found the vast majority of readmissions after pancreatic resection were to manage complications related to the operation and were not due to poor coordination of care or poor discharge planning. Because evidence-based measures to prevent these surgical complications do not exist, we cannot support the use of readmission rates themselves as a quality indicator after pancreatic surgery.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat “Medicaid Program; Payment adjustment for provider-preventable conditions including health care-acquired conditions.” Federal Register Vol. 76, No. 108. 6 Jun 2011, pp 32816–38. “Medicaid Program; Payment adjustment for provider-preventable conditions including health care-acquired conditions.” Federal Register Vol. 76, No. 108. 6 Jun 2011, pp 32816–38.
3.
Zurück zum Zitat Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1243–52; discussion 1252–3. Emick DM, Riall TS, Cameron JL, et al. Hospital readmission after pancreaticoduodenectomy. J Gastrointest Surg. 2006;10:1243–52; discussion 1252–3.
4.
Zurück zum Zitat Reddy DM, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13:1963–74; discussion 1974–5. Reddy DM, Townsend CM Jr, Kuo YF, Freeman JL, Goodwin JS, Riall TS. Readmission after pancreatectomy for pancreatic cancer in Medicare patients. J Gastrointest Surg. 2009;13:1963–74; discussion 1974–5.
5.
Zurück zum Zitat Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13:869–75.CrossRef Grewal SS, McClaine RJ, Schmulewitz N, et al. Factors associated with recidivism following pancreaticoduodenectomy. HPB (Oxford). 2011;13:869–75.CrossRef
6.
Zurück zum Zitat Kent TS, Sachs TE, Callery MP, Vollmer CM Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213:515–23.PubMedCrossRef Kent TS, Sachs TE, Callery MP, Vollmer CM Jr. Readmission after major pancreatic resection: a necessary evil? J Am Coll Surg. 2011;213:515–23.PubMedCrossRef
7.
Zurück zum Zitat DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, Clavien PA. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–9. DeOliveira ML, Winter JM, Schafer M, Cunningham SC, Cameron JL, Yeo CJ, Clavien PA. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006;244:931–7; discussion 937–9.
8.
Zurück zum Zitat Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138:8–13.PubMedCrossRef
9.
Zurück zum Zitat Brown RE, Qadan M, Martin RC 2nd, Polk HC Jr. The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg. 2010;211:558–60.PubMedCrossRef Brown RE, Qadan M, Martin RC 2nd, Polk HC Jr. The evolving importance of readmission data to the practicing surgeon. J Am Coll Surg. 2010;211:558–60.PubMedCrossRef
10.
Zurück zum Zitat Hackert T, Werner J and Buchler MW. Postoperative pancreatic fistula. Surgeon. 2011;9:211–7.PubMedCrossRef Hackert T, Werner J and Buchler MW. Postoperative pancreatic fistula. Surgeon. 2011;9:211–7.PubMedCrossRef
11.
Zurück zum Zitat Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.PubMedCrossRef Gouma DJ, van Geenen RC, van Gulik TM, de Haan RJ, de Wit LT, Busch OR, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232:786–95.PubMedCrossRef
12.
Zurück zum Zitat Makni A, Bedioui H, Jouini M, et al. Pancreaticojejunostomy vs. pancreaticogastrostomy following pancreaticoduodenectomy: results of comparative study. Minerva Chir. 2011;66:295–302.PubMed Makni A, Bedioui H, Jouini M, et al. Pancreaticojejunostomy vs. pancreaticogastrostomy following pancreaticoduodenectomy: results of comparative study. Minerva Chir. 2011;66:295–302.PubMed
13.
Zurück zum Zitat Pecorelli N, Balzano G, Capretti G, Zerbi A, Di Carlo V, Braga M. Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital. J Gastrointest Surg. 2012;16:518–23.PubMedCrossRef Pecorelli N, Balzano G, Capretti G, Zerbi A, Di Carlo V, Braga M. Effect of surgeon volume on outcome following pancreaticoduodenectomy in a high-volume hospital. J Gastrointest Surg. 2012;16:518–23.PubMedCrossRef
14.
Zurück zum Zitat Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef Traverso LW, Hashimoto Y. Delayed gastric emptying: the state of the highest level of evidence. J Hepatobiliary Pancreat Surg. 2008;15:262–9.PubMedCrossRef
15.
Zurück zum Zitat Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419–29.PubMedCrossRef Yeo CJ, Cameron JL, Lillemoe KD, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreaticoduodenectomy? Results of a prospective randomized placebo-controlled trial. Ann Surg. 2000;232:419–29.PubMedCrossRef
16.
Zurück zum Zitat Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;196:954–64.PubMedCrossRef Stojadinovic A, Brooks A, Hoos A, Jaques DP, Conlon KC, Brennan MF. An evidence-based approach to the surgical management of resectable pancreatic adenocarcinoma. J Am Coll Surg. 2003;196:954–64.PubMedCrossRef
17.
Zurück zum Zitat Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–72; discussion 772–4. Lillemoe KD, Cameron JL, Kim MP, Campbell KA, Sauter PK, Coleman JA, et al. Does fibrin glue sealant decrease the rate of pancreatic fistula after pancreaticoduodenectomy? Results of a prospective randomized trial. J Gastrointest Surg. 2004;8:766–72; discussion 772–4.
18.
Zurück zum Zitat Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11.PubMedCrossRef Fazio VW, Cohen Z, Fleshman JW, et al. Reduction in adhesive small-bowel obstruction by Seprafilm adhesion barrier after intestinal resection. Dis Colon Rectum. 2006;49:1–11.PubMedCrossRef
Metadaten
Titel
Readmission After Pancreatic Resection is not an Appropriate Measure of Quality
verfasst von
Irmina Gawlas, BA
Monica Sethi, MD
Megan Winner, MD, MS
Irene Epelboym, MD
James L. Lee, MD
Beth A. Schrope, MD, PhD
John A. Chabot, MD
John D. Allendorf, MD
Publikationsdatum
01.06.2013
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 6/2013
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-012-2763-y

Weitere Artikel der Ausgabe 6/2013

Annals of Surgical Oncology 6/2013 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.